Effect of E. cava and C. indicum Complex Extract on Phorbol 12-Myristate 13-Acetate (PMA)-Stimulated Inflammatory Response in Human Pulmonary Epithelial Cells and Particulate Matter (PM)2.5-Induced Pulmonary Inflammation in Mice
Pharmaceutics · 13.11.2023 · 15 (11) · 2621
DOI: 10.3390/pharmaceutics15112621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 13.11.2023. Verfasst von Sung-Gyu Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungnam, Republic of Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Oceans and Fisheries, Ministry of Oceans and Fisheries, Republic of Korea.
Abstract (Originalsprache)
This study explores the potential of a natural composite formulation known as ED, consisting of Ecklonia cava (E. cava, family: Lessoniaceae) and Chrysanthemum indicum Linne (C. indicum, family: Asteraceae), in alleviating lung inflammation induced by fine particulate matter (PM2.5). Initial assessments confirmed that neither ED nor one of its components, dieckol, exhibited cytotoxic effects on A549 cells. Subsequently, the impact of ED and dieckol on MUC5AC gene expression in A549 cells stimulated by phorbol 12-myristate 13-acetate (PMA) was investigated, revealing promising results that demonstrated a dose-dependent inhibition of MUC5AC gene expression. The study also delves into the underlying mechanisms, demonstrating that ED and dieckol effectively suppressed the phosphorylation of mitogen-activated protein kinases (MAPKs), including JNK, ERK, and p38, which are known to be involved in the regulation of MUC5AC gene expression. In in vivo experiments using a PM2.5-induced pulmonary inflammation mouse model, the research findings showed that ED mitigated cellular accumulation in the airways, leading to a significant reduction in the total cell count in bronchoalveolar lavage fluid (BALF). Moreover, ED exhibited protective effects against PM2.5-induced pulmonary damage, characterized by reduced inflammatory cell infiltration and decreased mucus secretion in pulmonary tissues. Additionally, ED’s anti-inflammatory properties were evident in its ability to decrease the levels of key inflammatory cytokines, TNF-α and IL-6, both in the serum and lung tissue of the PM2.5-induced pulmonary inflammation mouse model. These findings suggest the potential of ED as a therapeutic agent for inflammatory respiratory diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si 31116, Chungnam, Republic of Korea.
ORCID-Profile: Chan-Hwi Park
Förderung
- Ministry of Oceans and Fisheries
- Ministry of Oceans and Fisheries, Republic of Korea
Zitieren
APA
Lee, S. G., Park, C. H., & Kang, H. (2023). Effect of E. cava and C. indicum Complex Extract on Phorbol 12-Myristate 13-Acetate (PMA)-Stimulated Inflammatory Response in Human Pulmonary Epithelial Cells and Particulate Matter (PM)2.5-Induced Pulmonary Inflammation in Mice. Pharmaceutics, 15(11), 2621. https://doi.org/10.3390/pharmaceutics15112621
Vancouver
Lee SG, Park CH, Kang H. Effect of E. cava and C. indicum Complex Extract on Phorbol 12-Myristate 13-Acetate (PMA)-Stimulated Inflammatory Response in Human Pulmonary Epithelial Cells and Particulate Matter (PM)2.5-Induced Pulmonary Inflammation in Mice. Pharmaceutics. 2023;15(11):2621. doi:10.3390/pharmaceutics15112621
BibTeX
@article{Lee2023,
author = {Lee, Sung-Gyu and Park, Chan-Hwi and Kang, Hyun},
title = {Effect of E. cava and C. indicum Complex Extract on Phorbol 12-Myristate 13-Acetate (PMA)-Stimulated Inflammatory Response in Human Pulmonary Epithelial Cells and Particulate Matter (PM)2.5-Induced Pulmonary Inflammation in Mice},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {11},
pages = {2621},
doi = {10.3390/pharmaceutics15112621}
}
EUVIMED